Cellectis S.A. American Depositary Shares — Chart, Price & News (NASDAQ:CLLS)

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Market Capitalization 303.51 M
Employee 229
Founded 1999
CEO André Choulika
Website www.cellectis.com
Headquarter France
FIGI BBG0084L1XN2
Industry Technology

총매출

Net income

Total debt

Free cash flow

Cash & equivalents

303.51 M Market capitalization

Cellectis S.A. - American Depositary Shares

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

뉴스

셀렉티스(CLLS) 주식, 제프리스 ’매수’ 등급으로 커버리지 개시

Jefferies assumes coverage on Cellectis stock with Buy rating

This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Brunswick (NYSE:BC), Cellectis (NASDAQ:CLLS)

Clear Street, Cellectis에 ’매수’ 등급 제시… CAR-T 잠재력 주목

Clear Street initiates Cellectis stock with Buy rating on CAR-T potential

Cellectis: Showcasing Encouraging Data, But Still Early To Make A Run Like This (CLLS)

Allogene Arbitration Victory Pressures Cellectis Shares Tuesday - Allogene Therapeutics (NASDAQ:ALLO), Cellectis (NASDAQ:CLLS)

Lightwave Logic, Kyverna Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Argo Blockchain (NASDAQ:ARBK), Ascent Solar Technologies (NASDAQ:ASTI)

CLLS